TIBC

Total Iron Binding Capacity (Transferrin)

Metabolic Panel

What is Total Iron Binding Capacity (Transferrin)?

Total Iron Binding Capacity (TIBC) measures the maximum amount of iron that can be bound by proteins in the blood, primarily reflecting the concentration of transferrin, the main iron transport protein. Transferrin is a glycoprotein synthesized by the liver that carries iron through the bloodstream to sites of utilization (primarily the bone marrow for hemoglobin synthesis) and storage (liver, spleen, and bone marrow as ferritin). Each transferrin molecule can bind two atoms of ferric iron (Fe³⁺).

TIBC is an indirect measure of transferrin concentration and is part of the iron studies panel that includes serum iron, ferritin, and transferrin saturation (calculated as serum iron ÷ TIBC × 100). While transferrin can be measured directly by immunoassay, TIBC is often preferred because it is less expensive and provides functionally equivalent clinical information. TIBC inversely reflects iron stores—when iron stores are depleted, the liver increases transferrin production to maximize iron capture from the gut and tissues, raising TIBC. When iron stores are abundant, transferrin production decreases, lowering TIBC. This inverse relationship makes TIBC a valuable tool for distinguishing between causes of anemia and evaluating iron status.

Why It Matters

TIBC is essential for accurately interpreting iron status and distinguishing between the most common causes of anemia. Iron deficiency anemia (the most prevalent nutritional deficiency worldwide) is characterized by high TIBC (the body is producing more transferrin to capture scarce iron), while anemia of chronic disease shows low or normal TIBC (the body is sequestering iron during inflammation). This distinction is clinically critical because iron deficiency responds to iron supplementation, while anemia of chronic disease may worsen with iron therapy. TIBC is also valuable in detecting hemochromatosis and monitoring iron chelation therapy in transfusion-dependent patients.

Normal Reference Ranges

GroupRangeUnit
Adults250–370µg/dL
Children250–400µg/dL
Transferrin saturation20–50%

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High TIBC Levels Mean

Common Causes

  • Iron deficiency anemia (most common cause)
  • Pregnancy (estrogen stimulates transferrin production)
  • Oral contraceptive use
  • Acute hepatitis (increased hepatic transferrin synthesis)
  • Polycythemia vera

Possible Symptoms

  • Symptoms typically reflect underlying iron deficiency:
  • Fatigue and weakness
  • Pallor
  • Shortness of breath on exertion
  • Pica (craving non-food items: ice, clay, starch)
  • Restless legs syndrome
  • Koilonychia (spoon-shaped nails)

What to do: High TIBC with low serum iron and low ferritin confirms iron deficiency anemia. Investigate the cause: menstrual blood loss, gastrointestinal bleeding (colonoscopy/endoscopy if appropriate), malabsorption, or dietary insufficiency. Treat with oral iron supplementation (ferrous sulfate 325 mg containing 65 mg elemental iron, 1–3 times daily on empty stomach). If oral iron is not tolerated or absorbed, intravenous iron infusion may be necessary. Recheck iron studies in 4–8 weeks.

What Low TIBC Levels Mean

Common Causes

  • Anemia of chronic disease/inflammation
  • Iron overload (hemochromatosis)
  • Chronic liver disease and cirrhosis (reduced transferrin synthesis)
  • Nephrotic syndrome (urinary loss of transferrin)
  • Malnutrition and protein deficiency
  • Hereditary atransferrinemia (extremely rare)

Possible Symptoms

  • In iron overload: joint pain, skin bronzing, diabetes, liver disease, cardiomyopathy
  • In anemia of chronic disease: fatigue proportional to underlying illness
  • In liver disease: symptoms related to hepatic dysfunction
  • In nephrotic syndrome: edema, proteinuria

What to do: Low TIBC with high serum iron and high ferritin suggests iron overload—order transferrin saturation, HFE gene testing for hemochromatosis, and liver evaluation. Low TIBC with low serum iron and normal/high ferritin suggests anemia of chronic disease—treat the underlying inflammatory condition. In liver disease, address hepatic function. In nephrotic syndrome, manage proteinuria. The treatment approach depends entirely on the pattern of the full iron studies panel.

When Is TIBC Testing Recommended?

  • As part of a complete iron studies panel when anemia is detected
  • To distinguish iron deficiency anemia from anemia of chronic disease
  • When hemochromatosis or iron overload is suspected
  • During pregnancy to assess iron status
  • When monitoring response to iron supplementation or chelation therapy
  • When ferritin is borderline and clinical picture is ambiguous

Frequently Asked Questions

Transferrin saturation (TSAT) is calculated as (serum iron ÷ TIBC) × 100 and represents the percentage of iron-binding sites on transferrin that are currently occupied by iron. Normal TSAT is 20–50%. Values below 20% suggest iron deficiency, while values above 45% raise concern for iron overload. TSAT above 45% is the initial screening criterion for hemochromatosis—if elevated, HFE gene testing is recommended. TSAT is more useful than serum iron alone because serum iron fluctuates throughout the day and with meals, while the ratio accounts for the total binding capacity.
Individual iron study values can be misleading in isolation. Ferritin, for example, is an acute-phase reactant that rises with inflammation regardless of iron status—a patient can have iron deficiency masked by normal or high ferritin during infection. The pattern tells the story: iron deficiency shows low iron, high TIBC, low ferritin, and low TSAT. Anemia of chronic disease shows low iron, low TIBC, normal/high ferritin, and low TSAT. Iron overload shows high iron, low TIBC, high ferritin, and high TSAT. Mixed states (iron deficiency plus inflammation) require additional markers like soluble transferrin receptor to untangle.
TIBC and transferrin measure essentially the same thing—the iron-binding capacity of blood—but by different methods. Transferrin is measured by immunoassay (measuring the protein directly, reported in mg/dL). TIBC is a functional assay that saturates all binding sites with excess iron, removes the unbound iron, and measures the total iron bound (reported in µg/dL of iron). They can be approximately interconverted: TIBC (µg/dL) ≈ transferrin (mg/dL) × 1.4. TIBC is sometimes considered more clinically relevant because it reflects actual functional iron-binding capacity, while transferrin protein levels may not account for partially occupied binding sites.

Related Biomarkers

FeSerum IronFerritinFerritinHgbHemoglobinHctHematocritRBCRed Blood Cells

Want your TIBC levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.